Researchers analyzed blood samples for 175 people older than 80. Ninety-nine participants received their second Pfizer shot three weeks after their first, while 73 got their second shot 12 weeks after their first. Fifteen participants (10 in the three-week group and five in the 12-week group) who had prior COVID-19 infections were excluded from the analysis, as prior infection can play a major part in the immune response generated after vaccination.
The study found participants who received their second dose 12 weeks after their first produced a peak antibody response 3.5 times higher than participants who received their second dose 3 weeks after the first.
“This research is crucial, particularly in older people, as immune responses to vaccination deteriorate with age,” Helen Parry, MD, the study’s lead author, said in a news release. “Understanding how to optimise COVID-19 vaccine schedules and maximise immune responses within this age group is vitally important.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
